project id: TCGA-PAAD; case submitter id: TCGA-LB-A9Q5; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.19; rna integrity number: 7.2; age at index: 63; days to birth: -23218; days to death: 313; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1950; age at diagnosis: 23218; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 155.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 0.01643835616438356; pack years smoked: 0.3; years smoked: 2.0; is ffpe: false; composition: Not Reported; days to collection: 11; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-LB-A9Q5-01A-11; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 0.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;